HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Menglin Zhao Selected Research

Menglin Zhao Research Topics

Disease

4Neoplasms (Cancer)
01/2023 - 01/2021
3Neoplasm Metastasis (Metastasis)
01/2023 - 01/2022
3Stomach Neoplasms (Stomach Cancer)
01/2023 - 01/2021
1Atherosclerotic Plaque (Atheroma)
02/2024
1Vascular Calcification
02/2024
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2024
1Adenocarcinoma of Lung
08/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2023
1Lymphatic Metastasis
01/2023
1Hepatocellular Carcinoma (Hepatoma)
08/2022
1ST Elevation Myocardial Infarction
06/2022
1Neurofibrosarcoma (MPNST)
04/2022
1Adenocarcinoma
01/2022
1Diabetes Mellitus
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Heart Diseases (Heart Disease)
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Human Influenza (Influenza)
12/2021

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
1CalciumIBA
02/2024
1Aldehyde DehydrogenaseIBA
02/2024
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
02/2024
1Gefitinib (Iressa)FDA Link
08/2023
1osimertinibIBA
08/2023
1CrizotinibIBA
05/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023
1Cadherins (E-Cadherin)IBA
01/2023
1Cyclin D1IBA
08/2022
1AntigensIBA
08/2022
1Dacarbazine (DIC)FDA LinkGeneric
04/2022
1IfosfamideFDA LinkGeneric
04/2022
1Etoposide (VP 16)FDA LinkGeneric
04/2022
1Cisplatin (Platino)FDA LinkGeneric
04/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1plexinIBA
01/2022
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1VaccinesIBA
12/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1Caspase 9IBA
01/2021
1demethylzeylasteralIBA
01/2021

Therapy/Procedure

1Therapeutics
08/2023
1Percutaneous Coronary Intervention
06/2022
1Hysterectomy
04/2022
1Drug Therapy (Chemotherapy)
04/2022
1General Anesthesia
01/2022
1Liver Transplantation
01/2022